What's new

Human medicines European public assessment report (EPAR): Icandra (previously Vildagliptin / metformin hydrochloride Novartis), vildagliptin,metformin, Date of authorisation: 30/11/2008, Revision: 27, Status: Authorised

Human medicines European public assessment report (EPAR): Icandra (previously Vildagliptin / metformin hydrochloride Novartis), vildagliptin,metformin, Date of authorisation: 30/11/2008, Revision: 27, Status: Authorised

Feb 9, 2025 - 21:46
 0
Human medicines European public assessment report (EPAR): Icandra (previously Vildagliptin / metformin hydrochloride Novartis), vildagliptin,metformin, Date of authorisation: 30/11/2008, Revision: 27, Status: Authorised
Human medicines European public assessment report (EPAR): Icandra (previously Vildagliptin / metformin hydrochloride Novartis), vildagliptin,metformin, Date of authorisation: 30/11/2008, Revision: 27, Status: Authorised
Read More

Tags:

Previous Article

Human medicines European public assessment report (EPAR): Tevimbra, tislelizumab...

Next Article

Questions and answers on implementation of the medical devices and in vitro diag...

Related Posts

Human medicines European public assessment report (EPAR): Skojoy, aflibercept, Status: Application withdrawn

Human medicines European public assessment report (EPAR...

Mar 13, 2025  0

EMEA-001579-PIP01-13-M06

EMEA-001579-PIP01-13-M06

Apr 14, 2025  0

Human medicines European public assessment report (EPAR): EndolucinBeta, lutetium (177 Lu) chloride, Date of authorisation: 06/07/2016, Revision: 10, Status: Authorised

Human medicines European public assessment report (EPAR...

Mar 25, 2025  0